LONG-TERM NONPHARMACOLOGICAL TREATMENT FOR MILD TO MODERATE HYPERTENSION

被引:37
|
作者
JULA, A
RONNEMAA, T
RASTAS, M
KARVETTI, RL
MAKI, J
机构
[1] Rehabilitation Research Centre of the Social Insurance Institution, Turku
关键词
dietary fat; hypertension; physical exercise; relaxation training; serum lipids; sodium; weight reduction;
D O I
10.1111/j.1365-2796.1990.tb00180.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abstract. Ninety‐one middle‐aged men and women with untreated mild hypertension were allocated to a nopharmacological treatment group or to a control group. Members of the treatment group were instructed to reduce daily sodium intake to < 70 mmol, to reduce the intake of saturated fat, to lose weight if necessary and to perform regular physical exercise and relaxation training. Adherence to and effects of the programme on blood pressure and serum lipids were monitored for 12 months. In the treatment group, daily sodium excretion decreased to and remained at 50% of its original level (P < 0.001), and there was a significant reduction in saturated fat intake. The average weight reduction was modest. Adherence to physical exercise and relaxation training regimens was poor. The net decreases (difference in changes between treatment and control group) in blood pressure were greatest during the first 3 months: in men the decrease in systolic blood pressure was 11.3 mmHg (P < 0.001) and in diastolic blood pressure 8.3 mmHg (P < 0.001); in women the decrease in systolic blood pressure was 10.8 mmHg (P < 0.01) and in diastolic blood pressure 6.4 mmHg (P < 0.01). However, this decrease diminished during the last 3 months to approximately one half owing to blood pressure reduction in controls. Low density lipoprotein cholesterol levels decreased significantly in treated men and women. 1990 Blackwell Publishing Ltd
引用
收藏
页码:413 / 421
页数:9
相关论文
共 50 条
  • [21] CONSERVATIVE TREATMENT OF MILD MODERATE CERVICAL DYSKARYOSIS - LONG-TERM OUTCOME
    KIRBY, AJ
    SPIEGELHALTER, DJ
    DAY, NE
    FENTON, L
    SWANSON, K
    MANN, EMF
    MACGREGOR, JE
    LANCET, 1992, 339 (8797): : 828 - 831
  • [22] SAFETY AND EFFICACY OF AMLODIPINE IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION - A LONG-TERM STUDY WITH A NEW CALCIUM-ANTAGONIST
    HABELER, G
    LENZHOFER, R
    PALL, H
    TOMASCHEK, A
    ZIEBARTSCHROTH, A
    ZIRM, B
    GANZINGER, U
    WIENER KLINISCHE WOCHENSCHRIFT, 1992, 104 (01) : 16 - 20
  • [23] METABOLIC, HEMATOLOGICAL, AND CARDIAC EFFECTS OF LONG-TERM ISRADIPINE TREATMENT IN MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
    MERIC, M
    GOREN, T
    ATILGAN, D
    EREN, N
    CUBUKCU, A
    KOYLAN, N
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S58 - S60
  • [24] Basal and induced guanylate cyclase activity in patients with mild and moderate hypertension: Effect of long-term treatment with nebivolol
    Olbinskaya, LI
    Khapaev, BA
    Vartanova, OA
    KARDIOLOGIYA, 2000, 40 (08) : 8 - 12
  • [25] LONG-TERM EFFECTIVENESS OF BAY-E-5009-NITRENDIPINE IN THE TREATMENT OF MILD AND MODERATE ARTERIAL-HYPERTENSION
    ESPER, RJ
    ESPER, RC
    BAGLIVO, HP
    CASTRO, JM
    ROHWEDDER, RW
    MENNA, J
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 : 1096 - 1099
  • [26] A LONG-TERM STUDY OF DOXAZOSIN IN THE TREATMENT OF MILD OR MODERATE ESSENTIAL-HYPERTENSION IN GENERAL MEDICAL-PRACTICE
    MANOS, J
    AMERICAN HEART JOURNAL, 1991, 121 (01) : 346 - 351
  • [27] LONG-TERM COST-EFFECTIVENESS OF VARIOUS INITIAL MONOTHERAPIES FOR MILD TO MODERATE HYPERTENSION
    EDELSON, JT
    WEINSTEIN, MC
    TOSTESON, ANA
    WILLIAMS, L
    LEE, TH
    GOLDMAN, L
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (03): : 407 - 413
  • [28] LONG-TERM SAFETY AND EFFICACY OF GUANFACINE IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION
    MATHUR, PP
    SAVRAN, SV
    FILLINGIM, JM
    HOLMBURG, CE
    CANOSA, FL
    MCMILLEN, JI
    ARCHULETA, FM
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (06): : 1161 - 1168
  • [29] LONG-TERM ANTIHYPERTENSIVE EFFECTS AND SAFETY OF NITRENDIPINE IN PATIENTS WITH MILD, MODERATE, AND SEVERE HYPERTENSION
    KANN, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (12): : 945 - 950
  • [30] Long-term efficacy and safety of candesartan cilexetil in patients with mild-to-moderate hypertension
    Holzgreve, H
    JOURNAL OF HYPERTENSION, 1998, 16 : S214 - S214